NASDAQ:ACIU

Ac Immune Sa Stock News

Healthcare > Biotechnology

Buy ACIU

*Your capital is at risk

$2.50

+0.100 (+4.17%)

At Close: Jun 22, 2026

AC Immune to Present Progress of Alzheimer's Disease Programs targeting Abeta and Tau at the 15th CTAD Conference

07:30am, Wednesday, 23'rd Nov 2022

Lausanne, Switzerland, November 2 3 , 202 2 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced th

Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday

10:14am, Friday, 18'th Nov 2022 Benzinga

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. Elevate Credit, Inc. (NYSE: ELVT) shares jumped 68.9% to close at $1.79 on Thursday after the company ag

AC Immune to Present at the Jefferies London Healthcare Conference

12:58pm, Tuesday, 08'th Nov 2022 GlobeNewswire Inc.

LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today a

AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates

01:25pm, Friday, 28'th Oct 2022 Zacks Investment Research

AC Immune (ACIU) delivered earnings and revenue surprises of 29.17% and 457.95%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AC Immune Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

12:00pm, Friday, 28'th Oct 2022 GlobeNewswire Inc.

LAUSANNE, Switzerland, Oct. 28, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today r

AC Immune Opens New Centers in Phase 1b/2 Trial Evaluating ACI-24 Targeting Abeta in Alzheimer’s Disease and Down Syndrome

12:36pm, Tuesday, 04'th Oct 2022 GlobeNewswire Inc.

LAUSANNE, Switzerland, Oct. 04, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today p

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

09:09am, Thursday, 29'th Sep 2022 Benzinga

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The tria

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session

04:40pm, Wednesday, 28'th Sep 2022 Benzinga

Gainers Prothena Corporation plc (NASDAQ: PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s

AC Immune KOL Webinar on the Potential Benefits of Vaccines for Alzheimer’s and Parkinson’s Diseases

08:05pm, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.

LAUSANNE, Switzerland, Aug. 24, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (Nasdaq: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today h

Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket

11:36am, Tuesday, 23'rd Aug 2022 Benzinga

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss. Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) shares rose 34.5% t

Detailed Data From the Phase II Crenezumab Alzheimer’s Prevention Initiative Study in Autosomal Dominant Alzheimer’s Disease Presented at AAIC

03:00pm, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.

LAUSANNE, Switzerland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (Nasdaq: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today a

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by